DK121510B - Process for the preparation of therapeutically active 7α-methyl-Δ <5 (10)> estreners. - Google Patents

Process for the preparation of therapeutically active 7α-methyl-Δ <5 (10)> estreners.

Info

Publication number
DK121510B
DK121510B DK303365A DK303365A DK121510B DK 121510 B DK121510 B DK 121510B DK 303365 A DK303365 A DK 303365A DK 303365 A DK303365 A DK 303365A DK 121510 B DK121510 B DK 121510B
Authority
DK
Denmark
Prior art keywords
estreners
methyl
preparation
therapeutically active
therapeutically
Prior art date
Application number
DK303365A
Other languages
Danish (da)
Inventor
Jongh H De
Vliet N Van
Original Assignee
Org Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Org Nv filed Critical Org Nv
Publication of DK121510B publication Critical patent/DK121510B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK303365A 1964-06-17 1965-06-16 Process for the preparation of therapeutically active 7α-methyl-Δ <5 (10)> estreners. DK121510B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6406849A NL6406849A (en) 1964-06-17 1964-06-17

Publications (1)

Publication Number Publication Date
DK121510B true DK121510B (en) 1971-10-25

Family

ID=19790327

Family Applications (2)

Application Number Title Priority Date Filing Date
DK303365A DK121510B (en) 1964-06-17 1965-06-16 Process for the preparation of therapeutically active 7α-methyl-Δ <5 (10)> estreners.
DK501870A DK125773B (en) 1964-06-17 1970-10-01 7α-methyl-Δ <5 (10)> - oestriner for use as a contraceptive.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK501870A DK125773B (en) 1964-06-17 1970-10-01 7α-methyl-Δ <5 (10)> - oestriner for use as a contraceptive.

Country Status (9)

Country Link
BE (1) BE665515A (en)
BR (1) BR6570426D0 (en)
CH (1) CH487874A (en)
DE (1) DE1543270A1 (en)
DK (2) DK121510B (en)
FR (1) FR1604116A (en)
GB (1) GB1107553A (en)
NL (1) NL6406849A (en)
SE (1) SE336789B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6901532A (en) * 1969-01-30 1970-08-03
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators

Also Published As

Publication number Publication date
NL6406849A (en) 1965-12-20
BR6570426D0 (en) 1973-08-14
SE336789B (en) 1971-07-19
CH487874A (en) 1970-03-31
BE665515A (en)
DK125773B (en) 1973-05-07
FR1604116A (en) 1971-07-12
DE1543270A1 (en) 1969-07-31
GB1107553A (en) 1968-03-27

Similar Documents

Publication Publication Date Title
DK128353B (en) Analogous process for the preparation of therapeutically active bis-chromones.
DK111956B (en) Process for the preparation of 3,5-dioxo-17β-hydroxy-4,5-seco-Δ &lt;9&gt; ester.
DK114553B (en) Process for the preparation of biologically active 7α-methyl-3-keto-Δ &lt;5 (10)&gt; -estrenes.
DK123170B (en) Process for the preparation of therapeutically effective 3-oxo-7α-methyl-Δ &lt;4,9,11&gt; estratrienes.
DK117635B (en) Analogous process for the preparation of therapeutically active 3- (piperazinoalkyl) -pyrazoles.
DK115108B (en) Process for the preparation of 2-amino-benzophenone-β-oximes.
DK115547B (en) Process for the preparation of 17α-acyloxy-16-methyl-9α-fluor-Δ &lt;1,4&gt; -pregnadiene-3,20-diones.
DK118825B (en) Process for the preparation of adrenocorticotropically active tricosa or tetracosapeptides.
DK121510B (en) Process for the preparation of therapeutically active 7α-methyl-Δ &lt;5 (10)&gt; estreners.
DK114267B (en) Process for the preparation of therapeutically effective 17β-trialkylsiloxy-Δ &lt;4&gt; androstenes or estrenes.
DK116658B (en) Process for the preparation of therapeutically active 7α-methyl-Δ &lt;5&gt; -estrenes.
DK117488C (en) Process for the preparation of therapeutically active 2α-3α-epithio-5α-androstanes.
DK112235B (en) Process for the preparation of therapeutically effective 21-dicyclohexylmethyl carbonates of 21-hydroxy-Δ &lt;4&gt; -pregnen-17α-ol-3,20-diones.
DK116294B (en) Analogous process for the preparation of 4&#39;-demethyl-epipodophyllotoxin.
DK104301C (en) Process for the preparation of 3-hydroxy- or 3-hydrocarbon-Δ &lt;1,3,5 (10)&gt; - 19-nor-steroids.
DK122071B (en) Analogous process for the preparation of methylenebutyrylphenols.
DK114980B (en) Process for the preparation of sulfamylanthranilic acid amides.
DK129197B (en) Process for the preparation of 10-hydrocarbon-substituted 5-hydroxy-13β-alkyl-Δ &lt;9 (11)&gt; gones.
DK111487B (en) Process for the preparation of 17β-hydroxy- or 17β-alkanoyloxy-3-keto-Δ &lt;4.8 (14), 9&gt; -gonatrienes.
DK112318B (en) Process for the preparation of 2-benzenesulfonylamidopyrimidines.
DK111891B (en) Process for the preparation of 5-oxo-17α-methyl-20-hydroxy- (des-A) -19-nor-pregna-9-ene.
DK115694B (en) Process for the preparation of α-dithiols.
DK109329C (en) Process for the preparation of Δ &lt;4&gt; -6α-alkyl-19-nor-pregnenes.
DK106090C (en) Process for the preparation of 3-halogen-Δ &lt;5&gt; -19-nor-androstenes.
DK114552B (en) Process for the preparation of 1-methyl-Δ &lt;1&gt; -5α-androsten-17β-ol-3-one-17 esters.